The low number of patients included in our work probably explains that the difference in mortality is not significant because of a lack of statistical power, but we can notice a clear trend for fewer deaths in the TCZ group.
← all excerpts
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.
1
—
—